These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38361169)

  • 1. Behavioral Modeling and its Association with PrEP and ART Use in Ugandan HIV-Serodifferent Couples.
    Wang L; Muwonge TR; Simoni JM; Nambi F; Nakabugo L; Kibuuka J; Thomas D; Katz IT; Feutz E; Thomas KK; Ware NC; Wyatt MA; Kadama H; Mujugira A; Heffron R;
    AIDS Behav; 2024 May; 28(5):1719-1730. PubMed ID: 38361169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intimate Partner Violence and Adherence to PrEP and ART Among Ugandan HIV Serodifferent Couples.
    Thomas D; Nakabugo L; Nambi F; Kibuuka J; Muwonge TR; Feutz E; Thomas KK; Simoni JM; Montgomery ET; Ware N; Wyatt MA; Katz IT; Kadama H; Mujugira A; Heffron R;
    J Acquir Immune Defic Syndr; 2024 Apr; 95(4):347-354. PubMed ID: 38133584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrEP uptake and HIV viral suppression when PrEP is integrated into Ugandan ART clinics for HIV-negative members of HIV-serodifferent couples: A stepped wedge cluster randomized trial.
    Heffron R; Muwonge TR; Thomas KK; Nambi F; Nakabugo L; Kibuuka J; Thomas D; Feutz E; Meisner A; Ware NC; Wyatt MA; Simoni JM; Katz IT; Kadama H; Baeten JM; Mujugira A;
    EClinicalMedicine; 2022 Oct; 52():101611. PubMed ID: 35990584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Magnetic Couples Study: protocol for a mixed methods prospective cohort study of HIV-serodifferent heterosexual couples' perspectives and use of pre-exposure prophylaxis (PrEP).
    McMahon JM; Simmons J; Haberer JE; Mannheimer S; Leblanc NM; Torres L; Quiles R; Aedo G; Javier A; Braksmajer A; Harriman G; Trabold N; Pouget ER; Kurth A; Smith MDR; Brasch J; Podsiadly EJ; Anderson PL
    BMJ Open; 2021 Jul; 11(7):e048993. PubMed ID: 34210734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
    PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
    Rodger AJ; Cambiano V; Bruun T; Vernazza P; Collins S; Degen O; Corbelli GM; Estrada V; Geretti AM; Beloukas A; Raben D; Coll P; Antinori A; Nwokolo N; Rieger A; Prins JM; Blaxhult A; Weber R; Van Eeden A; Brockmeyer NH; Clarke A; Del Romero Guerrero J; Raffi F; Bogner JR; Wandeler G; Gerstoft J; Gutiérrez F; Brinkman K; Kitchen M; Ostergaard L; Leon A; Ristola M; Jessen H; Stellbrink HJ; Phillips AN; Lundgren J;
    Lancet; 2019 Jun; 393(10189):2428-2438. PubMed ID: 31056293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
    Rodger AJ; Cambiano V; Bruun T; Vernazza P; Collins S; van Lunzen J; Corbelli GM; Estrada V; Geretti AM; Beloukas A; Asboe D; Viciana P; Gutiérrez F; Clotet B; Pradier C; Gerstoft J; Weber R; Westling K; Wandeler G; Prins JM; Rieger A; Stoeckle M; Kümmerle T; Bini T; Ammassari A; Gilson R; Krznaric I; Ristola M; Zangerle R; Handberg P; Antela A; Allan S; Phillips AN; Lundgren J;
    JAMA; 2016 Jul; 316(2):171-81. PubMed ID: 27404185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
    Ware NC; Wyatt MA; Haberer JE; Baeten JM; Kintu A; Psaros C; Safren S; Tumwesigye E; Celum CL; Bangsberg DR
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):463-8. PubMed ID: 22267018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    Gilbert HN; Wyatt MA; Pisarski EE; Muwonge TR; Heffron R; Katabira ET; Celum CL; Baeten JM; Haberer JE; Ware NC
    J Acquir Immune Defic Syndr; 2019 Nov; 82(3):265-274. PubMed ID: 31609925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "It comes altogether as one:" perceptions of analytical treatment interruptions and partner protections among racial, ethnic, sex and gender diverse HIV serodifferent couples in the United States.
    Campbell DM; Dubé K; Cowlings PD; Dionicio P; Tam RM; Agarwal H; Stockman JK; Auerbach JD; Sauceda JA; Conroy AA; Johnson MO
    BMC Public Health; 2022 Jul; 22(1):1317. PubMed ID: 35810288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.
    Koss CA; Charlebois ED; Ayieko J; Kwarisiima D; Kabami J; Balzer LB; Atukunda M; Mwangwa F; Peng J; Mwinike Y; Owaraganise A; Chamie G; Jain V; Sang N; Olilo W; Brown LB; Marquez C; Zhang K; Ruel TD; Camlin CS; Rooney JF; Black D; Clark TD; Gandhi M; Cohen CR; Bukusi EA; Petersen ML; Kamya MR; Havlir DV;
    Lancet HIV; 2020 Apr; 7(4):e249-e261. PubMed ID: 32087152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation.
    Ngure K; Heffron R; Curran K; Vusha S; Ngutu M; Mugo N; Celum C; Baeten JM
    AIDS Patient Care STDS; 2016 Feb; 30(2):78-83. PubMed ID: 26836236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the Longitudinal Predictive Relationship Between HIV Treatment Outcomes and Pre-exposure Prophylaxis Use by Serodiscordant Male Couples.
    Jin H; Biello K; Garofalo R; Lurie M; Sullivan PS; Stephenson R; Mimiaga MJ
    J Acquir Immune Defic Syndr; 2021 Jan; 86(1):38-45. PubMed ID: 33027155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda.
    Ortblad KF; Stalter RM; Bukusi EA; Ngure K; Mujugura A; Celum C; Baeten JM; Heffron R
    AIDS Behav; 2020 May; 24(5):1365-1375. PubMed ID: 31696370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.
    Ying R; Sharma M; Heffron R; Celum CL; Baeten JM; Katabira E; Bulya N; Barnabas RV
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20013. PubMed ID: 26198348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples.
    Nakku-Joloba E; Pisarski EE; Wyatt MA; Muwonge TR; Asiimwe S; Celum CL; Baeten JM; Katabira ET; Ware NC
    J Int AIDS Soc; 2019 Jan; 22(1):e25225. PubMed ID: 30657642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
    AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "We are in this together:" dyadic-level influence and decision-making among HIV serodiscordant couples in Tanzania receiving access to PrEP.
    Fonner VA; Ntogwisangu J; Hamidu I; Joseph J; Fields J; Evans E; Kilewo J; Bailey C; Goldsamt L; Fisher CB; O'Reilly KR; Ruta T; Mbwambo J; Sweat MD
    BMC Public Health; 2021 Apr; 21(1):720. PubMed ID: 33853559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.